UDG Healthcare appoints Jez Moulding as Group Chief Operating Officer and Executive Vice President of Ashfield
UDG Healthcare plc (“the Group”), a leading international healthcare services provider, is pleased to announce the appointment of Jez Moulding as Chief Operating Officer (“COO”) of UDG Healthcare plc and Executive Vice President of Ashfield with effect from 2 May 2017
Jez
will oversee the Ashfield Division globally and will also have responsibility
for Group IT, Quality, Compliance, Strategy and Communications as part of his
role as COO of UDG Healthcare plc. The Sharp and Aquilant divisions will
continue to report directly to Brendan McAtamney, CEO of UDG Healthcare plc.
Jez
brings extensive international pharmaceutical experience to UDG having spent 18
years at Sanofi, holding numerous senior leadership positions across the globe,
in the UK, France, South Africa, Korea, Australia, Japan and the US. In his
most recent role as Senior Vice President and North America Region Head for
Diabetes and Cardiovascular, he was responsible for 3,500 employees and sales
of over $5 billion. Prior to joining Sanofi in 1999, Jez held a variety of
positions at Astra Pharmaceuticals and Winchester Pharmaceuticals in the UK.

Brendan
McAtamney, CEO of UDG Healthcare, said: “We are delighted to welcome Jez to UDG
Healthcare and to Ashfield. He has extensive leadership experience in the
pharmaceutical sector within our key global markets. His most recent experience
leading the Sanofi North American business will be extremely valuable to us as
we continue to develop our Ashfield US business and expand the Group
internationally.”
Jez
Moulding, incoming COO of UDG Healthcare plc and Executive Vice President of
Ashfield, said: “I am thrilled to be joining such a fast growing, dynamic team
in Ashfield and UDG Healthcare. Ashfield has grown over many years and is a
market leader in commercialisation services to global pharmaceutical clients. I
look forward to building on this strong platform and driving further
international expansion across the Group.”
As
previously announced, Chris Corbin will transition to the role of Chairman of
Ashfield and continue as a Non-Executive Director of UDG Healthcare.
For
more information on Ashfield please click
here, and for more information on UDG Healthcare please click
here
Contact
Website
Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK